MCRB
Seres Therapeutics Inc
3.80$
-5.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -272.0% | – | – | – | – | -3,521.3% | – | – | – | |
| – | +283.2% | +477.6% | +72.6% | +8.3% | -3.3% | -13.5% | -9.6% | +11.5% | -5.8% | -12.4% | -24.4% | |
| – | +368.8% | +73.9% | +3.0% | -4.2% | -49.9% | +5.8% | +129.2% | +26.0% | +33.8% | -38.5% | -48.3% | |
| – | +159.2% | +67.4% | +3.0% | -4.2% | -47.6% | +1.1% | +175.3% | +4.9% | – | – | – | |
| – | +37.9% | +3,556.8% | -109.2% | – | -308.7% | – | – | -144.3% | – | – | – | |
| – | +335.8% | +392.7% | -78.2% | -58.6% | -48.3% | -41.0% | +1,518.6% | +2.7% | -18.8% | -95.2% | -33.7% | |
| – | +12,332.7% | -52.3% | – | +97.1% | -127.2% | +420.6% | – | +28.6% | -87.2% | +1,244.7% | -100.0% | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -340.0% | – | -101.5% | +497.0% | – | +324.2% | -99.2% | +4,578.1% | – | – | – | |
| – | -262.5% | – | +0.0% | +0.0% | -1.7% | -103.9% | +0.0% | – | +96.6% | -353.2% | -100.0% | |
| – | +11.1% | -98.4% | -96.1% | +222.9% | +32,075.7% | +251.9% | -99.6% | +10,901.9% | -44.7% | -226.0% | – | |
| – | -135.8% | – | – | – | -141.8% | – | +41.3% | -123.3% | – | – | – | |
| – | – | – | -457.6% | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.